Talk about your hypocracy

There is a article

that would suggest that generic company’s products are not held to the same liability standards as the brand name product.

So the insurance industry is mandating generics both as generic substitution, therapeutic interchange and step therapy… to the point that some 75%-85% generic utilization is common place.

Is this the same industry – INSURANCE INDUSTRY – that benefits from not having to pay claims for claims against generic manufacturers?


Leave a Reply

Discover more from PHARMACIST STEVE

Subscribe now to keep reading and get access to the full archive.

Continue reading